Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women

被引:98
作者
Bélec, L
Ghys, PD
Hocini, H
Nkengasong, JN
Tranchot-Diallo, J
Diallo, MO
Ettiègne-Traore, V
Maurice, C
Becquart, P
Matta, M
Si-Mohamed, A
Chomont, N
Coulibaly, IM
Wiktor, SZ
Kazatchkine, MD
机构
[1] Hop Europeen Georges Pompidou, Virol Lab, F-75908 Paris 15, France
[2] Hop Broussais, INSERM, U430, F-75674 Paris, France
[3] Univ Paris 06, Paris, France
[4] Projet RETRO CI, Abidjan, Cote Ivoire
[5] Programme Natl Lutte SIDA Malad Sexuellement Tran, Abidjan, Cote Ivoire
[6] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1086/324375
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies to human immunodeficiency virus (HIV) of the IgA, IgG, and IgM isotypes and high levels of the HIV suppressive beta -chemokine RANTES (regulated on activation, normally T cell expressed and secreted) were found in the cervicovaginal secretions (CVSs) of 7.5% of 342 multiply and repeatedly exposed African HIV-seronegative female sex workers. The antibodies are part of a local compartmentalized secretory immune response to HIV, since they are present in vaginal fluids that are free of contaminating semen. Cervicovaginal antibodies showed a reproducible pattern of reactivity restricted to gp160 and p24. Locally produced anti-env antibodies exhibit reactivity toward the neutralizing ELDKWA epitope of gp41. Study results show that antibodies purified from CVSs block the transcytosis of cell-associated HIV through a tight epithelial monolayer in vitro. These findings suggest that genital resistance to HIV may involve HIV-specific cervicovaginal antibody responses in a minority of highly exposed HIV-seronegative women in association with other protecting factors, such as local production of HIV-suppressive chemokines.
引用
收藏
页码:1412 / 1422
页数:11
相关论文
共 55 条
[11]  
BELEC L, 1994, J CLIN MICROBIOL, V32, P1249
[12]   CERVICOVAGINAL OVERPRODUCTION OF SPECIFIC IGG TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CONTRASTS WITH NORMAL OR IMPAIRED IGA LOCAL RESPONSE IN HIV-INFECTION [J].
BELEC, L ;
DUPRE, T ;
PRAZUCK, T ;
TEVIBENISSAN, C ;
KANGA, JM ;
PATHEY, O ;
LU, XS ;
PILLOT, J .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :691-697
[13]  
BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57
[14]   PROINFLAMMATORY CYTOKINE EXPRESSION IN CERVICOVAGINAL SECRETIONS OF NORMAL AND HIV-INFECTED WOMEN [J].
BELEC, L ;
GHERARDI, R ;
PAYAN, C ;
PRAZUCK, T ;
MALKIN, JE ;
TEVIBENISSAN, C ;
PILLOT, J .
CYTOKINE, 1995, 7 (06) :568-574
[15]  
Bélec L, 1998, J VIROL, V72, P5831
[16]   LOCAL SYNTHESIS OF IGG ANTIBODIES TO HIV WITHIN THE FEMALE AND MALE GENITAL TRACTS DURING ASYMPTOMATIC AND PRE-AIDS STAGES OF HIV-INFECTION [J].
BELEC, L ;
TEVIBENISSAN, C ;
LU, XS ;
PRAZUCK, T ;
PILLOT, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (06) :719-729
[17]   Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type I highly exposed, persistently seronegative female sex workers in northern Thailand [J].
Beyrer, C ;
Artenstein, AW ;
Rugpao, S ;
Stephens, H ;
VanCott, TC ;
Robb, ML ;
Rinkaew, M ;
Birx, DL ;
Khamboonruang, C ;
Zimmerman, PA ;
Nelson, KE ;
Natpratan, C .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :59-67
[18]   Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women [J].
Biasin, M ;
Lo Caputo, S ;
Speciale, L ;
Colombo, F ;
Racioppi, L ;
Zagliani, A ;
Blé, C ;
Vichi, F ;
Cianferoni, L ;
Masci, AM ;
Villa, ML ;
Ferrante, P ;
Mazzotta, F ;
Clerici, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1365-1374
[19]   Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier [J].
Bomsel, M .
NATURE MEDICINE, 1997, 3 (01) :42-47
[20]   Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM [J].
Bomsel, M ;
Heyman, M ;
Hocini, H ;
Lagaye, S ;
Belec, L ;
Dupont, C ;
Desgranges, C .
IMMUNITY, 1998, 9 (02) :277-287